Literature DB >> 9221323

Red blood cell transfusions contaminated with Yersinia enterocolitica--United States, 1991-1996, and initiation of a national study to detect bacteria-associated transfusion reactions.

.   

Abstract

Although bacteremia and sepsis are infrequently reported complications of red blood cell (RBC) transfusion, receipt of transfused blood contaminated with bacterial pathogens may result in sepsis, disseminated intravascular coagulation, and death. Such pathogens have included Yersinia enterocolitica and Pseudomonas fluorescens. From November 1985 through February 1991, a total of 11 cases of sepsis associated with receipt of transfused Y. enterocolitica-contaminated RBCs were reported in the United States. This report describes an additional 10 cases of Y. enterocolitica sepsis reported to CDC during March 1991-November 1996 in patients who received transfusions with contaminated RBCs and describes the development of a study to detect bacteria-associated reactions to transfusion of RBCs and other blood components.

Entities:  

Mesh:

Year:  1997        PMID: 9221323

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  4 in total

Review 1.  Bacterial contamination of blood components.

Authors:  Mark E Brecher; Shauna N Hay
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

2.  Does recombinant human erythropoietin accelerate correction of post-ulcer-bleeding anaemia? A pilot study.

Authors:  Spiros D Ladas; Dimitrios Polymeros; Thomas Pagonis; Konstantinos Triantafyllou; Gregorios Paspatis; Maria Hatziargiriou; Sotirios A Raptis
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

3.  Cost and utilization of blood transfusion associated with spinal surgeries in the United States.

Authors:  Christopher M Blanchette; Peter F Wang; Ashish V Joshi; Mikael Asmussen; William Saunders; Peter Kruse
Journal:  Eur Spine J       Date:  2006-02-07       Impact factor: 3.134

4.  Delayed gastric emptying in critical illness: is enhanced enterogastric inhibition with cholecystokinin and peptide YY involved?

Authors:  Andrew J W Samis
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.